UK and US Launch Joint Regulatory Programme for Medicines and Healthcare Products
The Medicines and Healthcare Products Regulatory Agency and the US Food and Drug Administration have established a new liaison programme to strengthen cooperation on healthcare regulation. The initiative aims to streamline approval processes and enhance collaboration on medical innovation.